$2.43 -0.37 (-13.81%)

CytoMed Therapeutics Limited Ordinary Shares (GDTC)

CytoMed Therapeutics Limited is a biotechnology company focused on the development of cell-based immunotherapies for cancer treatment. The company specializes in innovative therapeutic platforms aimed at enhancing immune responses against tumors, with a focus on unmet medical needs in oncology.

🚫 CytoMed Therapeutics Limited Ordinary Shares does not pay dividends

Company News

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
GlobeNewswire Inc. • N/A • July 17, 2024

The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.

Wall Street Breakfast: The Week Ahead
Seeking Alpha • Wall Street Breakfast • April 14, 2024

Geopolitical tensions in the Middle East, earnings reports from major companies, and the upcoming bitcoin halving event are set to drive market focus this...

Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Avi Kapoor • February 7, 2024

Shares of The Container Store Group, Inc. (NYSE: TCS) shares fell sharply during Wednesday’s session following weak quarterly results. Container Store Group posted adjusted loss of 8 cents per share, compared to market expectations for a loss of 5 cents per share. The company’s quarterly sales came in at $214.90 million versus estimates of $...